Sharenet Sites 
Sharenet Sites
Trading statement – unaudited group results for the six months ended 30 September 2012
MEDICLINIC INTERNATIONAL LIMITED
(Incorporated in the Republic of South Africa)
(Registration number: 1983/010725/06)
(Share code: MDC)
(ISIN: ZAE000074142)
("Mediclinic" or “the Company”)
TRADING STATEMENT – UNAUDITED GROUP RESULTS FOR THE SIX MONTHS
ENDED 30 SEPTEMBER 2012
In terms of the JSE Limited (“JSE”) Listings Requirements,
companies are required to publish a trading statement as soon as
they are satisfied that a reasonable degree of certainty exists
that the financial results for the period to be reported upon next
will differ by at least 20% from that of the previous
corresponding reporting period. Mediclinic is in the process of
finalising its interim results for the six months ended
30 September 2012, which are due to be released on SENS on 6
November 2012 and published in the press on 7 November 2012
(“interim results announcement”).
Accordingly, shareholders are advised that the Company’s basic
earnings per share (“EPS”) and basic headline earnings per share
(“HEPS”) for the six months ended 30 September 2012 are expected
to be between 80% and 90% higher than that reported for the
previous corresponding reporting period (“the EPS and HEPS
range”).
In order to provide clear and meaningful guidance to shareholders,
this trading statement will also address normalised EPS and
normalised HEPS. Normalised EPS and normalised HEPS are defined as
reportable EPS and HEPS in terms of accounting standards,
excluding one-off items.
The one-off items are included in calculating the EPS and HEPS
range and relate to the net unrealised gains on foreign exchange
forward contracts entered into in order to hedge funds raised in
South Africa for offshore application. Details of one-off items
will be provided in the interim results announcement. Excluding
the one-off items, the normalised EPS and normalised HEPS for the
six months ended 30 September 2012 are expected to be between 40%
and 50% higher than the normalised EPS and normalised HEPS
reported for the previous corresponding reporting period.
The financial information on which this trading statement is based
has not been reviewed and reported on by the Company’s external
auditors.
Stellenbosch
26 October 2012
Mediclinic Offices, Strand Road, Stellenbosch 7600, South Africa
PO Box 456, Stellenbosch 7599, South Africa
Tel +27 21 809 6500
Fax +27 21 886 4037
Ethics line: 0800 005 316
Website: www.mediclinic.com
Sponsor
RAND MERCHANT BANK (A division of FirstRand Bank Limited)
Date: 26/10/2012 01:46:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE').
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.
